NKTR
NEKTAR THERAPEUTICSData as of 2026 Q2 (06-30) · 13F snapshot
Summary
NEKTAR THERAPEUTICS (NKTR) is held as common stock by 2 tracked hedge-fund managers, with a combined reported value of ~$44.53M; the largest are Izzy Englander, Ken Griffin. 3 tracked managers also disclosed PUT or CALL positions, reported separately below. This quarter: 1 added, 1 trimmed, 3 closed. 2 public STOCK Act / OGE trade disclosures are on record. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · LowThis quarter · Cooling
Common-stock holders23 also report options
Congress trades2
Price$60.40vs quarter-end-13.48%
Sectors0
This quarter's moves
Top holderNew0
Added1
Trimmed / sold4
Izzy EnglanderCommon-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
| Investor | Value | % of portfolio | Action |
|---|
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $12.25M— of portfolio175,5002026 Q2
Value $11.87M— of portfolio170,0002026 Q2
Value $11.43M— of portfolio163,8002026 Q2
Value $2.35M— of portfolio33,6002026 Q2
Value $216.4K— of portfolio3,1002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinPUT | $12.25M | — | — |
| Izzy EnglanderCALL | $11.87M | — | — |
| Ken GriffinCALL | $11.43M | — | — |
| Paul Tudor JonesCALL | $2.35M | — | — |
| Paul Tudor JonesPUT | $216.4K | — | — |
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.